
MOH
Molina Healthcare Inc Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$290.490
High
$290.490
Low
$290.490
Volume
0.17M
Company Fundamentals
Trading Stats
AI Analysis Report
Last updated: May 27, 2025MOH: Molina Healthcare Inc Common Stock – Decoding Recent Trends and Future Signals
Stock Symbol: MOH Generate Date: 2025-05-27 12:33:13
Let's break down what's been happening with Molina Healthcare and what the data might be telling us.
Recent News Buzz: A Mixed Bag with Positive Leanings
The news flow around Molina Healthcare has been quite active, showing a generally positive, though somewhat mixed, sentiment. Several analysts have been busy, mostly raising their price targets for the stock. For instance, Barclays bumped its target to $362, and Truist Securities went even higher to $400. Bernstein initiated coverage with an "Outperform" rating and a $414 target, which is a strong vote of confidence.
What's driving this? A big piece of good news came on April 8th: health insurance stocks, including Molina, got a lift because the government announced better-than-expected Medicare Advantage payment rates for 2026. This is a significant positive for a company like Molina, which heavily relies on these programs. Plus, the company itself reported solid first-quarter 2025 financial results, reaffirming its full-year guidance. That's always a good sign for stability.
However, it's not all sunshine. Baird did downgrade Molina from "Outperform" to "Neutral," even though they still raised their price target. And Guggenheim started coverage with a "Neutral" rating. So, while the overall mood from analysts leans positive with higher price targets, there are a few voices suggesting a more cautious stance.
Price Check: A Recent Dip After a Strong Run
Looking at the last 30 days of trading, Molina Healthcare's stock has seen some interesting moves. It had a pretty strong run leading up to early April, jumping from the high $200s to well over $350. That big jump around April 3rd and 4th likely reflects the positive sentiment building up, possibly tied to the Medicare news.
More recently, though, the price has pulled back. From a high of $353.24 on April 3rd, it's drifted down to a previous close of $309.77. This recent dip, especially after the strong run, could be seen as a bit of profit-taking or just the market digesting all the news. The trading volume has also been a bit up and down, with some days seeing higher activity during price drops.
Now, for today and the next couple of days, the AI model from AIPredictStock.com suggests some continued downward pressure. It predicts a -1.31% change for today and another -2.59% for tomorrow, followed by a slight rebound of 0.98% the day after. This indicates the recent downward trend might continue for a very short period.
Outlook & Ideas: Navigating the Current Waters
Putting it all together, the situation for Molina Healthcare seems to be one where strong underlying fundamentals and positive analyst sentiment are clashing with recent price weakness and short-term AI predictions of further dips.
The news, especially the Medicare payment rates and solid earnings, paints a picture of a healthy business. Analysts are generally optimistic, raising their price targets significantly. This suggests that over the medium to longer term, there's a good chance for the stock to move higher.
However, the recent price action and the AI's short-term forecast point to some immediate headwinds. The stock has pulled back, and the AI expects it to dip a bit more.
So, what does this mean for potential strategy?
- Apparent Near-Term Leaning: The immediate outlook, based on the AI's prediction and recent price action, leans towards a "hold" or even a cautious "wait and see" for new entries. The stock might see a bit more downward pressure before finding its footing.
- Potential Entry Consideration: If you're thinking about getting in, waiting for the predicted short-term dip to play out could be smart. The AI model points to a support level around $261.00, which is quite a bit lower than the current price. However, the recommendation data also highlights a strong buying opportunity around the current support level of $303.22. If the stock approaches or tests this $303-$304 area and shows signs of stabilizing, that could be a more attractive entry point than jumping in right now while it's still trending down.
- Potential Exit/Stop-Loss Consideration: For those already holding, keeping an eye on the $289.90 level as a potential stop-loss might be prudent. This is a level suggested by the recommendation data to manage risk if the downward trend accelerates beyond expectations. For taking profits, the average analyst price target is around $360.24, which offers significant upside from current levels. The recommendation data also suggests a take-profit target of $311.34 for short-term trading, which is very close to the current price, indicating a quick profit opportunity if the stock bounces.
Company Context: A Key Player in Healthcare Plans
Molina Healthcare operates in the "Healthcare Plans" industry, focusing on Medicaid and Medicare programs across 21 states. This means their business is directly impacted by government policies and reimbursement rates, as seen with the recent Medicare news. With 18,000 employees, they're a significant player. Their P/E ratio of 11.87 is in a neutral range, and while revenue growth is a bit lower than expected at 11.7%, their Return on Equity (ROE) at 26.7% is quite strong. The higher debt-to-equity ratio (87.38%) is something to keep in mind, but it's not uncommon in this capital-intensive sector.
Disclaimer: This analysis is for informational purposes only and should not be considered financial advice. Investing in stocks involves risks, and you could lose money. Always conduct your own thorough research and consult with a qualified financial professional before making any investment decisions.
Related News
Barclays Maintains Equal-Weight on Molina Healthcare, Lowers Price Target to $347
Barclays analyst Andrew Mok maintains Molina Healthcare with a Equal-Weight and lowers the price target from $351 to $347.
Morgan Stanley Initiates Coverage On Molina Healthcare with Overweight Rating, Announces Price Target of $364
Morgan Stanley analyst Erin Wright initiates coverage on Molina Healthcare with a Overweight rating and announces Price Target of $364.
Barclays Maintains Equal-Weight on Molina Healthcare, Lowers Price Target to $351
Barclays analyst Andrew Mok maintains Molina Healthcare with a Equal-Weight and lowers the price target from $362 to $351.
AI PredictionBeta
AI Recommendation
Updated at: Jun 12, 2025, 06:32 PM
65.1% Confidence
Risk & Trading
Entry Point
$292.42
Take Profit
$300.51
Stop Loss
$282.25
Key Factors
Related Stocks

TAK
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of)

KPTI
Karyopharm Therapeutics Inc.

MD
Pediatrix Medical Group Inc.

DAY
Dayforce

SLDB
Solid Biosciences Inc.
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.